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Depression and anxiety have a high prevalence in 
women during pregnancy and the postpartum period 
(Vesga-Lopez et al., 2008). The co-morbidity between 
anxiety and depression is higher than with any other 
mental disorder (Kendler et al., 1995). During preg-
nancy, depressive symptoms at the second trimester 
are predictive of high anxiety levels at the third trimes-
ter, which in turn predicts depressive symptoms in 
the postpartum period (Heron et al., 2004; Skouteris, 
Wertheim, Rallis, Milgrom, & Paxton, 2009). Overall, 
depressive and anxiety disorders during pregnancy 
seem to be important risk factors for postpartum 
depression (Grant, McMahon, & Austin, 2008; O’Hara & 
Swain, 1996; Sutter-Dallay, Giaconne-Marcesche, 
Glatigny-Dallay, & Verdoux, 2004) and to adverse 
child outcomes (Dunkel Schetter & Tanner, 2012). 
Nevertheless, depression and anxiety have been pointed 
out as being among the most overlooked diagnoses in 
primary care settings with true prevalence rates 5 to 10 
times higher than those usually reported (Bergink et al., 
2011). Thus, screening for these disorders during preg-
nancy and postpartum is warranted.
For depression, the Edinbugh Postnatal Depression 
Scale (EPDS) has been tested for women in the postna-
tal period (Areias, Kumar, Barros, & Figueiredo, 1996; 
Cox, Holden, & Sagovsky, 1987). Most studies testing 
the EPDS with a gold standard were undertaken with 
postpartum women, while few have done it with preg-
nant women (Gibson, McKenzie-McHarg, Shakespeare, 
Price, & Gray, 2009). Cross-cultural variation is dem-
onstrated by different EPDS cut-offs ranging from 10 
(Adewuya, Ola, Dada, & Fasoto, 2006) to 14/15 for 
pregnancy (Murray & Cox, 1990) and from 7 (Chaudron 
et al., 2010) to 11/12 for the postpartum (Benvenuti, 
Ferrara, Niccolai, Valoriani, & Cox, 1999).
For anxiety, the State-Trait Anxiety Inventory 
(STAI-S/T) original cut-off proposed by Spielberger, 
Gorsuch, and Lushene (1970) was used in most studies 
during the perinatal period. It was considered to be 
valid for antenatal use, since it reflects situation spe-
cific anxiety in high-risk compared to low-risk clinics 
(Gunning et al., 2010), nevertheless its reliability and 
validity for the pregnancy and postpartum period 
has been tested in very few studies which could lead to 
interpretation errors and incomparable data (Meades 
& Ayers, 2011).
Psychometric studies on general anxiety question-
naires are therefore needed. The lack of studies on this 
issue may be due to the fact that the STAI was not 
designed to provide a diagnosis of anxiety disorder. 
In one of those few studies, the best cut-off of the 
STAI-S for Australian childbearing women was found 
to be 40 for the prediction of postnatal anxiety and 
mood disorders (Grant et al., 2008), that matches the 
original cut-off (Spielberg et al., 1970). Despite that, 
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several different cut-offs for STAI were used in child-
bearing women.
During the antenatal period, a score of 40 or more 
was found to predict infant difficult temperament 
(Austin, Hadzi-Pavlovic, Leader, Saint, & Parker, 2005) 
while after childbirth it was found to be associated with 
a compromised quality of maternal behaviors during 
mother-infant interaction (Nicol-Harper, Harvey, & 
Stein 2007).
Considering the fact that both EPDS and STAI have 
been used extensively to assess depression and anxiety 
during the prenatal and postnatal period, there is a 
lack of studies attesting their psychometric properties 
for screening caseness against a clinical diagnostic inter-
view. Attending to the psychological and physiological 
changes that occur during this period, the establish-
ment of appropriate clinical cut-offs is relevant for 
screening and research purposes. The validation of 
these user-friendly measures could promote the wide-
spread screening of depression and anxiety during 
pregnancy and the postpartum periods as part of rou-
tine antenatal and postnatal care.
To our knowledge, this is the first study testing 
both the EPDS and STAI-S criterion validity against 
a diagnostic clinical interview (gold standard) in 
women before and after birth. This study aimed to 
test the screening performance of EPDS and STAI-S 
in detecting depressive (major and minor depression 
disorders and episodes, dysthymia) and anxiety dis-
orders (except specific phobias), respectively, at preg-
nancy and postpartum.
Method
Participants
Participants were derived from a larger study recruited 
in an Obstetrics Out-patients Unit (Oporto, Portugal) 
aimed to study anxiety and depression symptoms 
from early pregnancy to three months postpartum 
among women with low medical risk pregnancies and 
their partners. Women screening positive on EPDS 
(≥ 9, n = 44), STAI (≥ 45, n = 12) or both (n = 34) during 
pregnancy were selected, as well as matched controls 
(n = 58) based on socio-demographic characteristics, 
such as parity, age, socio-economical occupational 
and marital status. In total, 148 women were selected 
during pregnancy and 99 completed the postpartum 
assessment.
The great majority of the participants were Portuguese 
(90.5%) and Caucasian (91.9%). More than half of the 
participants were aged between 30 and 39 years old 
(M = 28.0; SD = 6.2), were married or cohabiting (84.8%), 
and lived with the partner without any other family 
members in the household (77.8%); and had no other 
child (56.8%).
Procedures
This study is part of a larger research that was con-
ducted according to prevailing ethical principles and 
received previous approval from the Maternity Hospital 
Ethical Commission. A random sample of pregnant 
women recruited in an Obstetrics Out-patients Unit 
(Oporto, Portugal) completed the STAI-S and EPDS 
during pregnancy (at 8-14, 20-24 and 30- 34 weeks) 
and at three months postpartum and provided socio-
demographic information. The exclusion criteria were 
not reading or writing Portuguese and multiple gesta-
tions. Further details on study design are described 
elsewhere (Figueiredo & Conde, 2011).
Women screening positive on EPDS (EPDS ≥ 9) or 
STAI-S (STAI-S ≥ 45) at any of the three time points 
during pregnancy and matched controls were admin-
istered the SCID about one week later by an interviewer 
blind to the EPDS and STAI-S scores.
The drop-out rate from pregnancy to postpartum 
was of 33.1%. To test for potential attrition bias we 
compared baseline data for women who withdrew after 
childbirth versus women who continued participating 
in the study and tested whether demographics were 
associated with drop out using independent samples 
t-tests and Pearson χ2 tests. We found no significant 
differences between both groups on EPDS and STAI-S 
mean scores during pregnancy, as well as no signifi-
cant association between prevalence of depression or 
anxiety diagnoses, prevalence of women who exceeded 
the cut-off values in one or both measures, age, parity, 
or marital status and group membership (all p > .05).
Measures
Socio-demographic questionnaire
Information about the participants (e.g., age, ethnicity, 
nationality, occupational and marital status, household 
arrangements, education level, medical and obstet-
rical history, psychological well-being and substances 
consumption).
State Anxiety Inventory
The State Anxiety Inventory is a twenty-item self-report 
scale designed for measuring the temporary condition of 
“state anxiety” (anxiety in a specific situation) (STAI-S/T: 
Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). 
Several studies have been using this instrument during 
pregnancy (e.g., Figueiredo & Conde, 2011; Teixeira, 
Figueiredo, Conde, Pacheco, & Costa, 2009). STAI-S 
Portuguese version has shown good internal consistency 
(Cronbach’s α = .87–.93) (Biaggio, Natalicio, & Spielberger, 
1976). In the present study, the internal consistency of 
the STAI-S for pregnancy and postpartum was excel-
lent (Cronbach’s α = .91 and .92, respectively).
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Edinburgh Postnatal Depression Scale
The Edinburgh Postnatal Depression Scale (EPDS: Cox 
et al., 1987) is a self-report questionnaire composed of 
10 items scored on a 4 point Likert scale (0-3), designed 
to assess postpartum depression. This scale addresses 
the intensity of depressive symptoms within the pre-
vious seven days and has been used in several studies 
both with pregnant and postpartum women, namely 
in Portugal (Areias et al., 1996; Figueiredo & Conde, 
2011; Figueiredo, Pacheco, & Costa, 2007; Teixeira et al., 
2009; Gorman et al., 2004). EPDS Portuguese version 
has shown good internal consistency (Cronbach’s 
α = .85) (Figueiredo et al., 2007). In the present study, 
the EPDS showed good internal consistency for preg-
nancy and postpartum (Cronbach’s α = .82 and .88).
Structured Clinical Interview
The Structured Clinical Interview for DSM-IV (SCID; 
First, Spitzer, Gibbon, & Williams, 1997) is a semi-
structured interview based on DSM-IV criteria for the 
diagnoses of mental disorders included on Axis I. The 
SCID has been validated for Portugal (Gorman et al., 
2004).
Data Analysis
Descriptive analyses were performed for demographic 
characteristics and scores on EPDS and STAI-S according 
to SCID diagnosis. Anxiety and depression caseness was 
based on the diagnoses provided by the SCID. Anxiety 
caseness included anxiety disorders, except specific 
phobias. Depression caseness included major and minor 
depression disorders and episodes, as well as dysthymia. 
To examine whether the EPDS and STAI-S can distin-
guish between depression and anxiety caseness, univar-
iate analysis of variance (ANOVA) followed by Scheffé 
post hoc tests were conducted comparing the four diag-
nostic groups: no diagnosis, depression caseness, anxiety 
caseness and co-morbid depression and anxiety caseness 
for pregnancy and the postpartum period.
Receiver operating characteristics (ROC) curve 
analyses were performed to determine the screening 
performance of the EPDS and the STAI-S in identifying 
women with depression and anxiety caseness, respec-
tively, for both pregnancy and postpartum. The area 
under the curve (AUC) provides an estimate of the 
overall diagnostic ability of the instrument with higher 
values indicating greater classification accuracy. The 
AUC of 0.5 represents classification by chance, whereas 
AUC of 0.7 is considered “acceptable”, 0.8 as “excel-
lent” and 0.9 as “outstanding” (Hosmer & Lemeshow, 
2000). Sensitivity, specificity, positive predictive values 
(PPV) and negative predictive values (NPV) for each 
EPDS and STAI-S cut-off scores were also computed. 
The EPDS scores were compared to the anxiety caseness, 
whereas the STAI-S scores against the depression case-
ness by additional ROC analyses to further examine the 
diagnostic ability of these instruments. The optimal 
cut-off score to each instrument and assessment period 
was determined by identifying the closest value to the 
intersection of the ROC curve with the diagonal line from 
the upper left to the lower right side of the graph. At this 
value an optimal balance between sensitivity and speci-
ficity is achieved (Bland, 2000).
Data were analysed with IBM SPSS 19 Windows ver-
sion (PASW Statistics for Windows, SPSS Inc, Chicago) 
and MedCalc 12.3.0.
Results
During pregnancy, 38 women (25.7%) were included 
on the depression caseness category and 35 women 
(23.6%) on the anxiety caseness since they were diag-
nosed with at least one depression or anxiety disorder, 
respectively. Twenty-one and six women met diagnos-
tic criteria for major and minor depressive episodes 
respectively, while one filled the criteria for major 
depression disorder. One woman had both a major 
depressive episode and bulimia and nine had co-morbid 
anxiety diagnoses. Furthermore, 26 women were diag-
nosed with an anxiety disorder including generalized 
anxiety disorder (GAD) (n = 16), agoraphobia (n = 6), 
GAD and agoraphobia (n = 1), panic disorder (n = 1), 
panic disorder with agoraphobia (n = 1) and obsessive-
compulsive disorder (n = 1). Other diagnoses included 
specific phobias (n = 8) and grief (n = 1).
At 3 months postpartum, 23 women (23.5%) were 
included on the depression caseness category and 14 
women (14.1%) on the anxiety caseness. Nine and six 
met criteria for major and minor depressive episodes, 
respectively, two were diagnosed with major depres-
sion disorder and one with dysthymia. Five cases had 
co-morbid depression and anxiety diagnoses. Moreover, 
nine women filled the criteria for an anxiety disorder 
at the postpartum including GAD (n = 3), agoraphobia 
(n = 2), panic disorder, panic disorder with agora-
phobia, obsessive-compulsive disorder and social pho-
bia (n = 1). Other diagnoses included specific phobias 
(n = 4) and grief (n = 1).
Screening performance of EPDS and STAI-S
Prenatal and postnatal EPDS and STAI-S scores according 
to DSM-IV-TR diagnostic criteria 
To explore the ability of the EPDS and the STAI-S to 
discriminate among the psychiatric diagnoses, uni-
variate ANOVAs with psychiatric diagnosis as the 
independent variable (no diagnosis vs. mood disor-
ders vs. anxiety disorders vs. co-morbid depression and 
anxiety) were conducted. The results of this analysis 
4  I. Tendais et al.
are displayed in Table 1. Overall differences were 
found in EPDS and STAI-S mean scores across the four 
psychiatric diagnoses during pregnancy (F(3, 135) = 
29.03 and F(3, 135) = 15.28, p < .001) and at postpar-
tum (F(3, 90) = 26.09 and F(3, 90) = 11.21, p < .001). 
Scheffé post hoc tests revealed that women with no 
psychiatric diagnosis had significantly lower EPDS 
and STAI-S scores than the other groups with mood, 
anxiety or co-morbid depression and anxiety (all p < .05). 
However, no differences were found between the three 
psychiatric diagnoses groups on EPDS and STAI-S 
total scores (all p > .05).
Diagnostic accuracy of the EPDS during pregnancy 
and postpartum
Table 2 and Figure 1 show the results of the ROC 
analysis in differentiating depression caseness from non-
depression (including normal cases and all the other 
psychopathological disorders) for pregnancy and the 
postpartum. The AUC for the total score of the EPDS was 
.83 (95% C.I. = .76-.899, p < .001) for pregnancy and .88 
(95% C.I. = .78-.97, p < .001) for postpartum, indicating an 
excellent classification accuracy power. The optimal bal-
ance between sensitivity and specificity was achieved at 
a cut-off ≥ 9 for pregnancy (sensitivity = 73.7% and speci-
ficity = 70.0%). For the postpartum, a lower cut-off score 
of ≥ 7 seemed to be appropriate (sensitivity = 78.3% and 
specificity = 81.6%). At these cut-offs 70.9% and 80.8% 
of women were correctly classified.
To examine the screening ability of the EPDS to 
detect women with or without an anxiety disorder, 
ROC analyses with anxiety caseness as the criterion 
were conducted. The AUC for pregnancy was .71 
(95% C.I. = .62-.79, p < .001) and .78 (95% C.I. = .64-.91, 
p = .001) for the postpartum.
Diagnostic accuracy of the STAI-S during pregnancy 
and postpartum
Table 2 and Figure 2 show the results of the ROC analyses 
in differentiating anxiety caseness from non-anxiety 
(including normal cases and all the other psychopath-
ological disorders) for pregnancy and the postpartum. 
The AUC for the total score of the STAI-S was .73 (95% 
C.I. = .65-.81, p < .01) for pregnancy and .76 (95% C.I. = 
.62-.89, p < .05) for postpartum. The optimal balance 
between sensitivity and specificity was achieved at a 
cut-off ≥ 40 for pregnancy (sensitivity = 65.7% and 
specificity = 67.3%). A lower cut-off score (34) was 
found to be the optimal score for screening anxiety 
caseness at the postpartum (sensitivity = 71.4% and 
specificity = 67.1%). At these cut-offs 66.9% and 67.7% 
of women were correctly classified.
Additional ROC analyses were conducted to exam-
ine the screening ability of STAI-S using depression 
caseness as the criterion. The AUC for pregnancy was 
.72 (95% C.I. = .62-.81, p < .001) and for the postpartum 
was .75 (95% C.I. = .64-.86, p < .001).
Discussion
The results of the present study show that the EPDS 
and the STAI-S were both reasonably valid instruments 
for identifying maternal depressive and anxiety disor-
ders during pregnancy and the postpartum period in 
a community sample of women.
At pregnancy and postpartum periods, the EPDS 
has demonstrated a high level of diagnostic ability in 
distinguishing between depressed and non-depressed 
women, whereas STAI-S revealed an acceptable diag-
nostic ability in distinguishing between anxious and 
non-anxious women. The EPDS performed satisfacto-
rily as a diagnostic instrument of anxiety disorders at 
both time periods. Previous studies had suggested that 
at least some items of the EPDS could be used to detect 
anxiety disorders (e.g., Mathey, 2008; Rowe, Fisher, & 
Loh, 2008). Similarly, STAI-S was found to be as accu-
rate to detect anxiety disorders as to detect depressive 
disorders in the postpartum as it has already been 
found for other periods of the life course (Kvaal, Ulstein, 
Nordhus, & Engedal, 2005).
This indicates that depressive and anxiety disorders 
during pregnancy and the postpartum periods are 
Table 1. EPDS and STAI-S scores according to SCID diagnosis at pregnancy and postpartum
SCID
Pregnancy Postpartum
n EPDS M (SD) STAI-S M (SD) n EPDS M (SD) STAI-S M (SD)
No diagnosis 75 5.91 (3.8) 34.92 (8.9) 62 3.89 (3.0) 29.61 (6.7)
Mood disorders 29 12.10 (3.4) 44.41 (11.7) 18 10.72 (5.3) 40.17 (12.6)
Anxiety disorders 26 10.00 (2.8) 42.96 (6.8) 9 7.56 (3.8) 39.56 (10.9)
Co-morbid mood and anxiety disorders 9 13.11 (4.8) 52.33 (12.1) 5 14.40 (3.6) 43.40 (10.2)
F (df) 29.03 (3,135)*** 15.28 (3,135)*** 26.09 (3,90)*** 11.21 (3,90)***
Note: Women with other diagnoses at pregnancy (n=9) and at the postpartum (n = 5) were excluded from these analyses.
*** p < .001.
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probably not independent clinical entities. Previous 
studies had already reported that the EPDS does not 
distinguish depression from anxiety disorders in the 
postpartum period (Rowe et al., 2008), nor does the 
STAI-S in clinical samples of adults and older adults 
(Kennedy, Schwab, Morris, & Beldia 2001; Kvaal et al., 
2005). An overlap between depression and anxiety 
symptoms has been consistently recognized (e.g., 
Kennedy et al., 2001; Meades & Ayers, 2011). Some 
empirical and theoretical explanations have been pro-
posed to explain this finding. First, although the EPDS 
was originally designed to measure depression (Cox 
et al., 1987), some studies have demonstrated the exis-
tence of an anxiety dimension (Mathey, 2008; Pop, 
Komproe, & Van Son, 1992; Reichenheim, Moraes, 
Oliveira, & Lobato, 2011). However, the separate use 
of this subscale is not recommended (Brouwers, van 
Baar, & Pop, 2001; Pop et al., 1992; Reichenheim et al., 
2011; Rowe et al., 2008). Second, there is also some evi-
dence that postpartum depression has prominent 
anxious features (Hendrick, Altshuler, Strouse, & Grosser, 
2000). Third, several authors suggest that STAI is also 
sensitive to depressive disorders (Kennedy et al., 2001; 
Kvaal et al., 2005). Fourth, Clark, and Watson (1991) 
proposed that anxiety and depression have a common 
dimension called general distress or negative affect.
For EPDS, the optimal cut-off score was 9 for preg-
nancy and 7 for the postpartum. These are somewhat 
Table 2. Diagnostic performance of EPDS and STAI-S for detection of depression and anxiety caseness, respectively (%)
Threshold Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Accuracy
EPDS
Pregnancya 8 86.8 (71.9 – 95.6) 59.1 (49.3 – 68.4) 42.3 (31.2 – 54.0) 92.9 (84.1 - 97.6) 66.2
9 73.7 (56.9 – 86.6) 70.0 (60.5 – 78.4) 45.9 (33.1 – 59.2) 88.5 (79.8 – 94.4) 70.9
10 65.8 (48.6 – 80.4) 80.0 (71.3 – 87.0) 53.2 (37.9 – 68.0) 87.1 (79.0 – 93.0) 76.4
11 55.3 (38.3 – 71.4) 85.5 (77.5 – 91.5) 56.8 (39.5 – 72.9) 84.7 (76.6 – 90.8) 77.7
12 47.4 (31.0 – 64.2) 91.8 (85.0 – 96.2) 66.7 (45.6 – 83.8) 83.5 (75.6 – 89.6) 80.4
Postpartumb 6 82.6 (61.2 – 95.0) 73.7 (62.3 – 83.1) 48.7 (32.4 – 65.2) 93.3 (83.8 – 98.2) 75.8
7 78.3 (56.3 – 92.5) 81.6 (71.0 – 89.5) 56.3 (37.7 – 73.6) 92.5 (83.4 – 97.5) 80.8
8 78.3 (56.3 – 92.5) 90.8 (81.9 – 96.2) 72.0 (50.1 – 88.2) 93.2 (84.9 – 97.8) 87.9
9 65.2 (42.7 – 83.6) 94.7 (87.1 – 98.5) 78.9 (54.4 – 93.9) 90.0 (81.2 – 95.6) 87.9
11 52.2 (30.6 – 73.2) 97.4 (90.8 – 99.7) 85.7 (55.8 – 98.4) 87.1 (78.0 – 93.4) 86.9
12 47.8 (26.8 – 69.4) 98.7 (92.9 – 100.0) 91.7 (61.5 – 99.8) 86.2 (77.1 – 92.7) 86.9
STAI-S
Pregnancyc 34 88.6 (73.3 – 96.8) 45.1 (35.8 – 54.8) 33.3 (23.9 – 43.9) 92.7 (82.4 – 98.0) 55.4
35 85.7 (69.7 – 95.2) 46.9 (37.5 – 56.5) 33.3 (23.7 – 44.1) 91.4 (81.0 – 97.1) 56.1
36 85.7 (69.7 – 95.2) 54.0 (44.4 – 63.4) 36.6 (26.2 – 48.0) 92.4 (83.2 – 97.5) 61.5
37 80.0 (63.1 – 91.6) 57.5 (47.9 – 66.8) 36.8 (26.1 – 48.7) 90.3 (81.0 – 96.0) 62.8
38 77.1 (59.9 – 89.6) 60.2 (50.5 – 69.3) 37.5 (26.4 – 49.7) 89.5 (80.3 – 95.3) 64.2
39 71.4 (53.7 – 85.4) 65.5 (56.0 – 74.2) 39.1 (27.0 – 52.2) 88.1 (79.2 – 94.1) 66.9
40 65.7 (47.8 – 80.9) 67.3 (57.8 – 75.8) 38.3 (26.0 – 51.9) 86.4 (77.4 – 92.8) 66.9
41 62.9 (44.9 – 78.5) 69.0 (59.6 – 77.4) 38.6 (26.0 – 52.4) 85.7 (76.8 – 92.2) 67.6
42 60.0 (42.1 – 76.1) 70.8 (61.5 – 79.0) 38.9 (25.9 – 53.1) 85.1 (76.2 – 91.6) 68.2
43 57.1 (39.4 – 73.7) 73.5 (64.3 – 81.3) 40.0 (26.3 – 55.0) 84.7 (76.0 – 91.2) 69.6
44 51.4 (34.0 – 68.6) 75.2 (66.2 – 82.9) 39.1 (25.1 – 54.6) 83.3 (74.6 – 90.0) 69.6
45 42.9 (26.3 – 60.6) 77.9 (69.1 – 85.1) 37.5 (22.7 – 54.2) 81.5 (72.8 – 88.3) 69.6
Postpartumd 34 71.4 (66.1 – 99.8) 67.1 (56.0 – 76.9) 26.3 (13.4 – 43.1) 93.4 (83.9 – 98.2) 67.7
35 57.1 (66.1 – 99.8) 69.4 (58.5 – 79.0) 23.5 (10.7 – 41.2) 90.8 (81.0 – 96.5) 67.7
36 57.1 (66.1 – 99.8) 71.8 (61.0 – 81.0) 25.0 (11.3 – 43.7) 91.0 (81.5 – 96.6) 69.7
37 57.1 (57.2 – 98.2) 75.3 (64.7 – 84.0) 27.6 (12.7 – 47.2) 91.4 (82.3 – 96.8) 72.7
38 57.1 (28.9 – 82.3) 81.2 (71.2 – 88.8) 33.3 (15.3 – 55.8) 92.0 (83.4 – 97.0) 77.8
39 50.0 (23.0 – 77.0) 83.5 (73.9 – 90.7) 33.3 (14.2 – 57.6) 91.0 (82.4 – 96.3) 78.8
40 50.0 (23.0 – 77.0) 85.9 (76.6 – 92.5) 36.8 (16.3 – 61.6) 91.2 (82.8 – 96.4) 80.8
41 50.0 (23.0 – 77.0) 89.4 (80.8 – 95.0) 43.8 (19.1 – 71.0) 91.6 (83.4 – 96.5) 83.8
43 50.0 (23.0 – 77.0) 91.8 (83.8 – 96.6) 50.0 (23.0 – 77.0) 91.8 (83.8 – 96.6) 85.9
44 42.9 (17.7 – 71.1) 91.8 (83.8 – 96.6) 46.2 (19.2 – 74.9) 90.7 (82.5 – 95.9) 84.8
Note: PPV Positive predictive value, NPV Negative predictive value; a n = 148; 38 included in the depression caseness; 
b n = 99; 23 included in the depression caseness; c n = 148; 35 included in the anxiety caseness; d n = 99; 14 included in the anxiety 
caseness. Values in bold represent the most adequate balance between sensitivity and specificity.
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Figure 2. ROC curve. Anxiety2 at pregnancy and postpartum versus non-anxiety.
2Anxiety versus non-anxiety: pregnancy (n = 35 versus n = 113), postpartum (n = 14 versus n = 85).
lower cut-offs than suggested in previous studies carried 
out during pregnancy (e.g., Adewuya et al., 2006), but 
within the range of published cut-offs for the postpar-
tum (Chaudron et al., 2010). This may be at least partly 
explained by the inclusion of minor depressive disor-
ders and episodes besides major depressive disorders. 
Lower optimal cut-offs scores and lower sensitivity 
have been reported when minor depression disor-
ders were included (Chaudron et al., 2010; Eberhard-
Gran, Eskild, Tambs, Opjordsmoen, & Samuelsen, 
2001; Matthey, Barnett, Kavanagh, & Howie, 2001). 
Moreover, in the depressed caseness group of our sam-
ple most women had less severe diagnosis of depres-
sion. The sensitivity of the EPDS at pregnancy and 
postpartum period for the optimal cut-off score are 
low but comparable to those found in other validation 
studies (Eberhard-Gran et al., 2001; Gibson et al., 
2009).
For the STAI-S, the optimal cut-off score was 40 for 
pregnancy and 34 for the postpartum. The cut-point 
for pregnancy is consistent with previous reports (Grant 
et al., 2008), although higher sensitivity, specificity and 
negative predictive value, but lower positive predictive 
value was reported. The existing differences may be 
partly explained by the differing time span in which 
STAI-S was administered. In the present study, state 
anxiety was assessed during pregnancy, whilst Grant 
et al. (2008) assessed anxiety only in the last trimester 
of pregnancy. At the optimal cut-off scores for preg-
nancy and postpartum period, the sensitivity of the 
Figure 1. ROC curve. Depression1 at pregnancy and postpartum versus non-depression.
1Depression versus non-depression: pregnancy (n = 38 versus n = 110), postpartum (n = 23 versus n = 76).
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STAI-S for anxiety disorders was moderate. Therefore, 
additional screening for anxiety disorders with specific 
self-report measures during the perinatal period may 
be recommended as previously suggested by others 
(Muzik et al., 2000; Ross & McLean, 2006).
Considering that depressive and anxiety disorders 
in women are common mental disorders during preg-
nancy and the postpartum and the potential for impact 
on the fetus/ infant health and development (Dunkel 
Schetter & Tanner, 2012), the use of valid, reliable and 
easy to complete short self-report instruments is rec-
ommended. Screening for depressive and anxiety dis-
orders using EPDS and STAI-S during the prenatal 
period as part of the routine care may provide an easy 
and low cost strategy to detect and provide adequate 
treatment and simultaneously to identify those who are 
at-risk for these disorders at the postpartum period. 
However, this study shows that both EPDS and STAI-S 
miss a significant number of cases and generate a 
considerable proportion of false positives as most 
screening instruments (Gibson et al., 2009).
The reported results should be interpreted in the 
context of several limitations. First, the similarity in 
baseline characteristics between those lost to follow-up 
and those remaining in the study to the end is not 
sufficient to exclude the possibility of attrition bias. In 
fact, recent studies suggest that postpartum depression 
is associated to miss postpartum follow-up (Lobato, 
Bruner, Dias, Moraes, & Reichenheim, 2012). Second, 
given the lower sensitivity, specificity and PPV at the 
optimal cut-off of the STAI-S during pregnancy and 
postpartum, we cannot exclude the possibility that the 
SCID criteria for anxiety disorders were applied less 
strictly than the Mini- Plus Neuropsychiatric Interview 
in another study where STAI-S was used at the third 
trimester of pregnancy (Grant et al., 2008). Third, the 
small sample size (with only 14 anxiety cases postpar-
tum) is also a limitation that might have resulted in 
poor statistical power to distinguish between cases and 
non-cases of anxiety disorders with the STAI-S.
Even with these limitations, this longitudinal study 
demonstrates that EPDS and STAI-S are reasonably 
valid screening tools for depression and anxiety disor-
ders for use during pregnancy and postpartum.
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